HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Anthracosis

A diffuse parenchymal lung disease caused by accumulation of inhaled CARBON or coal dust. The disease can progress from asymptomatic anthracosis to massive lung fibrosis. This lung lesion usually occurs in coal miners, but can be seen in urban dwellers and tobacco smokers.
Also Known As:
Black Lung; Coal Miner's Lung; Coalworker's Pneumoconiosis; Pneumoconiosis, Coal Worker's; Anthracoses; Black Lung Diseases; Black Lungs; Coal Miner Lung; Coal Miner's Lungs; Coal Miners Lung; Coal Worker Pneumoconiosis; Coal Worker's Pneumoconioses; Coal Workers Pneumoconiosis; Coalworker Pneumoconiosis; Coalworker's Pneumoconioses; Coalworkers Pneumoconiosis; Lung, Black; Lungs, Black; Miner's Lung, Coal; Miner's Lungs, Coal; Pneumoconioses, Coal Worker's; Pneumoconioses, Coalworker's; Pneumoconiosis, Coal Worker; Pneumoconiosis, Coal Workers; Pneumoconiosis, Coalworker's; Black Lung Disease; Coal Worker's Pneumoconiosis
Networked: 207 relevant articles (2 outcomes, 20 trials/studies) for this Disease, Comments

Relationship Network

Disease Context: Research Results

Related Diseases

1. Respiratory Insufficiency (Respiratory Failure)
2. Fibrosis (Cirrhosis)
3. Chronic Bronchitis
4. Infection
5. Sleep Initiation and Maintenance Disorders (Insomnia)

Experts

1. Huang, Xi: 4 articles (08/2005 - 09/2002)
2. Kart, Levent: 4 articles (01/2005 - 08/2004)
3. Altin, Remzi: 4 articles (01/2005 - 08/2004)
4. Centers for Disease Control and Prevention (CDC): 3 articles (12/2009 - 04/2003)
5. Yucesoy, Berran: 3 articles (10/2008 - 04/2007)
6. Karakaya, Asuman: 3 articles (10/2008 - 04/2007)
7. Savranlar, Ahmet: 3 articles (11/2004 - 08/2004)
8. Zhang, Qi: 3 articles (07/2003 - 09/2002)
9. Yu, Chen: 2 articles (04/2009 - 08/2004)
10. Qi, Fang: 2 articles (04/2009 - 08/2004)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Anthracosis:
1. CoalIBA
2. Pentetic Acid (DTPA)FDA LinkGeneric
3. diethylenetriamineIBA
4. Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
5. QuartzIBA
6. Interleukin-6 (Interleukin 6)IBA
7. Pyridoxine (Pyridoxin)FDA Link
8. Methionine (L-Methionine)FDA Link
9. Interleukin-1 (Interleukin 1)IBA
10. Interleukin-6 Receptors (Interleukin 6 Receptor)IBA

Therapies and Procedures

1. X-Ray Film
2. Artificial Respiration (Mechanical Ventilation)
3. Massage (Reflexology)
4. Drug Therapy (Chemotherapy)
5. Lung Transplantation

blog comments powered by Disqus
TREATMENT OPTIONS
for Anthracosis,
Ranking and Evidence
*WARNING* This specific disease subtype has a relatively small number of significant evidence outcomes. You may proceed to order anyway, or go back to the search field and enter a more general type of the target illness. Once your report has been ordered, however, we can't refund the purchase.

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. Analytic charts allow you and your physicians to see at a glance the treatment options—including new, promising, off-label and experimental.
  • Free Updates for 1 Year
  • All 2 Outcomes
  • Top 200 Key Drugs and Biologics
  • Top 50 Key Therapies and Procedures
  • Detailed History Charts
  • Full Research Evidence References
  • Sample PDF Report on Psoriasis >>
Price:$8.50 USD & Delivery via PDF download
updates for 1 year
Research Interface PRO

Rapidly retrieve clinical outcome summaries for all evidence of drug efficacy against any disease in seconds. Click "Charts" to view graphs of relative efficacy of all drugs against any known disease. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time. Save hours of search and analysis time:
Price:$45.00 USD access via web interface
1 year subscription
Request Bulk Institution License Details >>